(Q82673267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFalpha and rituximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

inclusion body myositis

1 reference

1 reference

Stefan Vordenbäumen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eva Neuen-Jacob

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jutta Richter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Matthias Schneider

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

27 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

555-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

Inclusion body myositis in association with rheumatoid arthritis

17 January 2020

cites work

1 reference

12 December 2020

Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis

1 reference

12 December 2020

Autoimmune Diseases Induced by TNF-Targeted Therapies

1 reference

12 December 2020

The therapeutic dilemma of inclusion body myositis.

1 reference

12 December 2020

A case of inclusion body myositis responsive to prednisolone therapy

1 reference

12 December 2020

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

1 reference

12 December 2020

Pilot trial of etanercept in the treatment of inclusion-body myositis

1 reference

12 December 2020

A local antigen-driven humoral response is present in the inflammatory myopathies

1 reference

12 December 2020

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo.

1 reference

12 December 2020

Inclusion body myositis in connective tissue disorders: case report and review of the literature

1 reference

12 December 2020

Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis

1 reference

12 December 2020

Sporadic inclusion body myositis: pathogenic considerations

1 reference

12 December 2020

Inclusion body myositis: morphological clues to correct diagnosis

1 reference

12 December 2020

Inclusion body myositis: new insights into pathogenesis

1 reference

12 December 2020

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.

1 reference

12 December 2020

Inclusion body myositis evolving in systemic lupus erythrematosus? A case report

1 reference

12 December 2020

High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study

1 reference

12 December 2020

A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.

1 reference

12 December 2020

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

1 reference

12 December 2020

Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features

1 reference

12 December 2020

Idiopathic inflammatory myopathies: current and future therapeutic options.

1 reference

12 December 2020

10.1007/S10067-009-1367-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20108015%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference